Research output per year
Research output per year
Personal profile
CV
1.2 Exams and academic degrees
Qualified as a doctor (cand. med.) from the University of Copenhagen, Denmark, January 1977.
European Certification on Medical Oncology, October 1991.
Medical Oncologist's Recertification Approval, August 2000.
Doctor of Medical Science (dr. med.), University of Copenhagen, June 1992.
Declared qualified for a Professorship in Clinical Oncology, Copenhagen University, 2006.
1.3 Registrations
Fully registered by the National Board of Health of Denmark, December 1979.
Fully registered by the General Medical Council, UK, March 1982.
Specialist in Oncology, February 1992.
1.4 Honorary awards
Prize of the Danish Society of Oncology ("Onkologi-prisen") 2004.
2.1 Previous appointments
Dept. of Medicine, York District Hospital, England
Locum Junior House Officer, 01.06.77 - 31.07.77
Dept. of Diagnostic Radiology, The Finsen Institute
House Officer, 15.08.77 - 31.05.78
Dept. of Sugery, The Finsen Institute
House Officer, 01.06.78 - 31.05.79
Dept. of Medicine, The Finsen Institute
House Officer (internship), 01.06.79 - 30.11.79
Dept. of Surgery, The Finsen Institute
House Officer, 01.12.79 - 31.12.79
Dept. of Medicine, The Finsen Institute
Locum House Officer, 01.01.80 - 31.03.80
Dept. of Medicine, The Finsen Institute
House Officer, 01.04.80 - 31.10.82
The last 6 months as Senior House Officer
Dept. of Medicine, Roskilde Hospital
Senior House Officer, 01.05.83 - 30.11.83
Dept. of Medicine (Med. 4), Copenhagen Municipal Hospital
House Officer, 01.12.83 - 14.01.85
Dept. of Oncology I, Section A, The Finsen Institute
House Officer, 15.01.85 - 31.01.86
Dept. of Medicine, The Finsen Institute
Clinical Research Fellowship (funded by The Danish Cancer Society)
01.02.86 - 30.09.88
Dept. of Oncology, Herlev Hospital
House Officer (training position in Oncology)
01.10.88 - 31.03.90
Dept. of Oncology, Herlev Hospital
Senior Registrar, 01.04.90 - 31.10.92
Dept. of Oncology, Rigshospitalet
Senior Registrar, 01.11.92 - 31.07.94
Dept. of Oncology, Herlev Hospital
Senior Consultant, 01.08.94 - 31.12.00
Danish Medicines Agency
Assessor in Oncology and Haematology,
Licensing Division, 01.01.2006 - 31.08.09
2.2 Present appointments
Dept. of Oncology, The Finsen Centre, Rigshospitalet
Senior Consultant, 01.01.01 - cont.
01.09.07 - 31.08.09, 50 % time for research, funded by The Novo Nordisk Foundation.
From 1.1.2008 Chairman of the Research Committee,
Depts. of Oncology and Radiotherapy, The Finsen Centre Rigshospitalet.
The Faculty of Health Sciences, Copenhagen University,
Department of Surgery and Internal Medicine
Associate Professor, PhD Section, 01.02.03 - 31.08.09
Professor of Oncology, 01.09.09 - cont.
Primary fields of research
Prognostic factors in Hodgkin lymphoma
Radiotherapy of Hodgkin lymphoma
Long-term complications form the treatment of Hodgkin lymphoma
FDG-PET in the evaluation and treatment of patients with Hodgkin lymphoma
Radiotherapy of non Hodgkin lymphoma, in particulat indolent B-cell lymphomas and cutaneous T-celle lymphomas
Respiratory adapted radiotherapy, in particular for breast cancer, lung cancer and malignant lymphoma
Highly conformal radiotherapy techniques, in particular for nasopharyngeal cancer and malignant lymphoma
Advanced imaging and radiotherapy for head and neck cancer
Knowledge of languages
Fluent in Danish and EnglishExpertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Keywords
- Faculty of Health and Medical Sciences
- Prognostic factors in Hodgkin lymphoma
- Radiotherapy of Hodgkin lymphoma
- Long-term complications form the treatment of Hodgkin lymphoma
- FDG-PET in the evaluation and treatment of patients with Hodgkin lymphoma
- Radiotherapy of non Hodgkin lymphoma
- Respiratory adapted radiotherapy, in particular for breast cancer, lung cancer and malignant lymphoma
- Highly conformal radiotherapy techniques, in particular for nasopharyngeal cancer and malignant lymphoma
- Advanced imaging and radiotherapy for head and neck cancer
Fingerprint
Dive into the research topics where Lena Specht is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
-
Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation
Sengeløv, H., Petersen, P. M., Fog, L., Schmidt, M. & Specht, L., 1 Aug 2019, In: Bone Marrow Transplantation. 54, 8, p. 1369-1371 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer
Håkansson, K., Rasmussen, J. H., Bentzen, S. M., Friborg, J., Specht, L. & Vogelius, I. R., 4 Mar 2019, In: Acta Oncologica. 58, 3, p. 390-392 3 p.Research output: Contribution to journal › Comment/debate › Research
-
A clinical prognostic model compared to the newly adopted UICC staging in an independent validation cohort of P16 negative/positive head and neck cancer patients
Rasmussen, J. H., Håkansson, K., Rasmussen, G. B., Vogelius, I. R., Friborg, J., Fischer, B. M., Bentzen, S. M. & Specht, L., Jun 2018, In: Oral Oncology. 81, p. 52-60Research output: Contribution to journal › Journal article › Research › peer-review
-
An extended hypofractionated palliative radiotherapy regimen for head and neck carcinomas
Laursen, M., Specht, L., Kristensen, C. A., Gothelf, A., Bernsdorf, M., Vogelius, I. & Friborg, J., 2018, In: Frontiers in Oncology. 8, JUN, 8 p., 206.Research output: Contribution to journal › Journal article › Research › peer-review
-
Coplanar and non-coplanar VMAT facilitate OAR dose sparing in central lung SBRT
Thomsen, J. B., Persson, G. F., Aznar, M. C., Berthelsen, A. K., Specht, L. & Josipovic, M., 20 Apr 2018, In: Radiotherapy & Oncology. 127, Supp.1, p. S1021-S1021 EP-1886.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
DAHANCA 10: Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
Overgaard, J., Hoff, C. M., Hansen, H. S., Specht, L., Overgaard, M., Lassen, P., Andersen, E., Johansen, J., Andersen, L. J., Evensen, J. F., Alsner, J. & Grau, C., Apr 2018, In: Radiotherapy & Oncology. 127, 1, p. 12-19Research output: Contribution to journal › Journal article › Research › peer-review
-
Deep inspiration breath hold and locally advanced lung cancer: validation of geometrical uncertainties
Josipovic, M., Aznar, M., Damkjær, S., Thomsen, J., Rydhög, J., Nygård, L., Specht, L., Pøhl, M. & Persson, G., 2018, In: Radiotherapy and Oncology. 127, Supplement 1, p. S1102-S1103 EP-2020.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature
Grønhøj, C., Jensen, D. H., Agander, T., Kiss, K., Høgdall, E., Specht, L., Bagger, F. O., Nielsen, F. C. & von Buchwald, C., 7 Jun 2018, In: BMC Cancer. 18, 1, p. 1-10 10 p., 640.Research output: Contribution to journal › Journal article › Research › peer-review